Systematic review / meta-analysis / 2021
In a meta-analysis of prospective cohort studies, mushroom intake was linked to a lower risk of all-cause mortality.
Researchers analyzed 30,378 NHANES participants over a mean follow-up of 6.7 years and conducted a meta-analysis combining these data with four other prospective cohort studies (totaling 601,893 individuals). In NHANES, mushroom consumption showed a non-significant association with all-cause mortality after multivariable adjustments (adjusted HR 0.84; 95% CI: 0.67-1.06; 2,855 deaths). However, the meta-analysis found that mushroom consumption was associated with a lower risk of all-cause mortality (pooled risk ratio 0.94; 95% CI: 0.91, 0.98).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study and meta-analysis of prospective cohort studies
- Who was studied
- 30,378 NHANES participants (2003-2014); 601,893 individuals across 5 cohorts in meta-analysis
- What was measured
- All-cause mortality
THE PAPER
Prospective study of dietary mushroom intake and risk of mortality: results from continuous National Health and Nutrition Examination Survey (NHANES) 2003-2014 and a meta-analysis.
Ba DM, Gao X, Al-Shaar L, Muscat J, Chinchilli VM, Ssentongo P, Zhang X, Liu G, Beelman RB, Richie JP. Nutr J, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.